In this article the authors examined the characteristics of COVID-19 severity in an international sample of people with MS.

The objective of this study was to identify the prevalence of EEG abnormalities in patients with COVID-19 with neurologic changes, their associated neuroimaging abnormalities and rates of mortality.

In this article the authors aimed to determine the frequency and diagnostic features of COVID-19 related AE.

In this article the authors performed high-dimensional characterization of the pathophysiological and immune traits of aged COVID-19 convalescents, and correlated the local and systemic immune profiles with pulmonary function and lung imaging.

In this article the authors longitudinally profiled vaccine responses in SARS-CoV-2 naïve and recovered individuals for 6 months after vaccination.

A systematic review of 735 SARS-CoV-2-associated deaths using conventional autopsy, ultrasound-guided autopsy, postmortem CT and medical records.

This Review provides the structural and cellular foundations for understanding the multistep SARS-CoV-2 entry process.

In this article the authors analysed the development of anti-SARS-CoV-2 antibody and T cell responses in previously infected (recovered) or uninfected (naive) individuals that received mRNA vaccines to SARS-CoV-2.

The aim of this study was to estimate weather-dependent signatures in the early phase of the pandemic, while controlling for socio-economic factors and non-pharmaceutical interventions.

The authors of this study aimed to characterise myofiber structure in the diaphragm of critically ill patients with COVID-19.

The objective of this study was to determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19.

Evaluation of the effects of therapeutic-dose low-molecular-weight heparin vs institutional standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19.

The objective of this study was to assess reports of GBS received in the Vaccine Adverse Event Reporting System (VAERS) following Ad26.COV2.S vaccination.

The objective of this study was to investigate the association between risk of COVID-19 in nonimmune individuals and the number of their family members with known immunity acquired from a previous COVID-19 infection or full vaccination (2 vaccine doses).

The objective of this study was to assess whether anticoagulant or antiplatelet therapy can safely reduce major adverse cardiopulmonary outcomes among symptomatic but clinically stable outpatients with COVID-19.